Drug intelligence / Profile preview

soluble Klotho

Development stage
Preclinical
Lead developer
Jocasta Neuroscience
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous
01

Overview

Soluble Klotho (sKlotho) is the circulating, shed extracellular domain of the transmembrane α-Klotho protein, which is primarily expressed in the kidneys and choroid plexus. It is generated through proteolytic cleavage of membrane-bound α-Klotho by secretases (such as ADAM10 and ADAM17) or via alternative splicing of the Klotho gene. Soluble Klotho acts as an endocrine and paracrine hormone with pleiotropic cytoprotective, anti-inflammatory, anti-oxidative, and anti-fibrotic effects. It plays a critical role in the regulation of mineral metabolism, calcium and phosphate homeostasis, and vascular health. In preclinical models, exogenous administration of recombinant soluble Klotho has shown therapeutic potential in chronic kidney disease (CKD), diabetic kidney disease (DKD), cardiovascular diseases, and neurodegenerative disorders. However, as of 2026, it is primarily utilized as a research reagent, with therapeutic candidates (such as recombinant proteins and gene therapies) remaining in preclinical development.

Other names
s-KLsKlothosecreted Klothosoluble alpha-Klothosoluble α-Klotho
02

Targets

FGF23 (Fibroblast growth factor 23)FGFR1 (Fibroblast growth factor receptor 1)LGALS1 (Galectin-1)IGF-1R (Insulin-like growth factor 1 receptor)TGFBR2 (TGF-β receptor type 2)TRPV (TRPV channel family)Wnt (Wnt ligand)

Beyond the preview

Go deeper on soluble Klotho.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on soluble Klotho.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call